Clinical trial · Observational
NYSCF Scientific Discovery Biobank
NCT06203106CI-TRIAL-00086708recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
Conditions
Conditions (29)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ALS | — | UNRESOLVED | — |
| Alzheimer Disease | — | UNRESOLVED | — |
| Alzheimer Disease, Early Onset | — | UNRESOLVED | — |
| Alzheimer Disease, Late Onset | — | UNRESOLVED | — |
| Amyotrophic Lateral Sclerosis | — | UNRESOLVED | — |
| Batten Disease | — | UNRESOLVED | — |
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Corticobasal Degeneration | — | UNRESOLVED | — |
| Dementia | — | UNRESOLVED | — |
| Diabetes | — | UNRESOLVED | — |
| Diabetes Mellitus | — | UNRESOLVED |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biological Sample Collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Affected Subjects
- description
- Subjects in this group will have a diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest.
- interventionNames
- Other: Biological Sample Collection
- label
- Healthy Control
- description
- Subjects in this group will serve as healthy controls.
- interventionNames
- Other: Biological Sample Collection
Primary outcomes (1)
- measure
- Biobank
- timeFrame
- Baseline
- description
- Establishment of a diverse repository of biological samples, stem cell lines, derivatives, and associated information to support investigations into the biology, etiology, manifestations, progression, risk factors, genetic underpinnings, and treatment of diseases, conditions, and traits.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Days
Show eligibility criteria text
Inclusion Criteria: * Age 30 days or older. * Diagnosis and/or medical history of a condition, disease, genetic background, or trait of interest or healthy control. * Adults with decisional capacity must provide written informed consent unless physical limitations preclude signing. * Adults without decisional capacity to consent must a have diagnosis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease and Related Dementias (AD/ADRD); Batten Disease, Corticobasal Degeneration (CBD), Dementia, Frontotemporal Dementia (FTD), Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson's Disease (PD), Parkinsonism, and/or Progressive Supranuclear Palsy, and must provide assent; a legally authorized representative (LAR) must also provide written informed consent. * Minors undergoing skin collection for research purposes must have a condition, disease, genetic background, or trait of interest and parental/guardian consent. * Minors undergoing blood, and/or saliva collection for research purposes may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent. * Minors transferring biological samples and associated data from a procedure outside of the research may have a condition, disease, genetic background, or trait of interest or serve as a healthy control and must have an available parent/guardian to provide consent. Exclusion Criteria: * Wards of the state. * For prospective skin samples: history of keloid formation, coagulation disorder, or allergy to the anesthetic. * For prospective blood samples: history of coagulation disorder. * For all prospective sample collections: 1) Subjects who refuse to adhere to NYSCF's and/or a collection site's safety protocol(s) will be excluded; 2) Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of blood will be excluded due to increased risk of infection.
References
Publications (0)
Data not yet available
No reference posted for this study.